ISI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ionis Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 72 EUR 1.1% Market Closed

Market Cap: €10.5B

I	Ionis Pharmaceuticals Inc F:ISI	US
H	Halliburton Co SWB:HAL	US
A	Archer-Daniels-Midland Co XBER:ADM	US
J	Jefferies Financial Group Inc DUS:LN3	US
	Sectra AB STO:SECT B	SE
	NetEase Inc F:4Y01	CN
E	Eli Lilly and Co F:LLY	US
A	Arista Networks Inc F:117	US
M	Mettler-Toledo International Inc XMUN:MTO	US

Profitability Summary

Ionis Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

99%

Declining Gross Margin

99% > 98%

Negative Operating Margin

-33%

Negative 3Y Average Operating Margin

-51%

Operating Margin is Increasing

-75% > -33%

Negative Net Margin

-31%

Negative 3Y Average Net Margin

-46%

Net Margin is Increasing

-49% > -31%

Negative Free Cash Flow Margin

-92%

Negative 3Y Average Free Cash Flow Margin

-57%

Declining Free Cash Flow Margin

-77% > -92%

Negative ROE

-68%

Negative 3Y Average ROE

Positive 3Y Average ROIC

20%

Declining ROIC

-105% > -258%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.